logo
15:53 Feb 25

Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1030.30
-16.20 (-1.55%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Beta Drugs Ltd. Financials

Beta Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1030.30
-16.20 (-1.55%)
15:53 Feb 25
Quality
image/svg+xml

37/100
Medium Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

25/100
Technically Bearish

Strength

5

Weakness

12

Opportunity

1

Threats

0

21.52 %

ROE %

9.72 %

ROA %

41.08

EPS

195.25

BVPS

11.70 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
183.84 227.11 295.71 362.36 384.63
Operating Expenses +
141.14 173.99 235.72 287.75 309.29
Raw Material
96.21 110.4 167.65 175.78 181.25
Increase Decrease in Cost
-1.75 -4.71 -18.24 -4.42 -2.2
Other Manufacturing Expense
17.78 24.29 31.79 40.62 0
Employee Cost
15.91 22.7 25.89 33.92 39.81
Miscellaneous Expenses
12.99 21.31 28.63 41.85 90.43
Operating Profit
42.7 53.12 59.99 74.61 75.34
Other Income
0.76 0.75 1.36 6.44 12.25
Depreciation
7.25 10.41 9.78 12.51 15.93
Interest
1.9 2.41 2.82 6.99 14.65
Profit before tax and exceptio..
34.3 41.06 48.75 61.54 57.01
Exceptional Items
0 0 0 -4.57 -2.22
PBT
34.3 41.06 48.75 56.97 59.23
Provision for Taxation
9.47 10.34 12.32 14.55 13.33
Net Profit
24.83 30.72 36.44 42.42 41.47
NET Profit after MI
24.83 30.72 36.44 42.42 41.47
EPS
25.82 31.95 37.9 42.02 41.04
Operating Profit Margin (%)
23.23 23.39 20.29 20.59 19.59
Net Profit Margin (%)
13.51 13.53 12.32 11.71 10.78

Beta Drugs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 64.90 66.70 66.70 66.70 66.70 66.70
FII 1.10 0.90 0.90 0.90 1.20 1.20
Public 1.90 0.30 0.30 0.20 0.10 0.10
Others 32.10 32.10 32.10 32.20 32.00 32.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: